Research areas
► government ethics and the regulation of health care (e.g., conflicts of interest, lobbying, revolving door, transparency)
► Food and Drug Administration (FDA)
► technologies (e.g., drugs, devices, AI, cybersecurity)
Metholodogical approach
► guided by economic and sociological theory
► quantitative (statistical / econometric) methods
► large administrative, survey, and other datasets
Recent Activity
>> New Publication <<
March 7, 2025
Unregulated large language models produce medical device-like output. npj Digital Medicine 2025; 4:148.
>> New Publication <<
September 20, 2024
Lessons from the Change Healthcare Ransomware Attack. JAMA Health Forum 2024; 5:e242764.
Public Comment
August 13, 2024
Comment on Optimizing the FDA’s Use of and Processes for Advisory Committees [Docket No. FDA-2024-N-1809]
CNBC
March 27, 2025
US health department plans to slash 10,000 jobs as RFK Jr upends agencies
by Annika Kim Constantino
Newsmax
America Right Now
March 1, 2025
Trump 2.0: Department of Health and Human Services [video @ 00:40]
Interview with Tom Basile
STAT News
November 24, 2024
Trump’s pick to run FDA is top exec of company that provides compounded weight-loss drugs (paywall) [PDF]
by John Wilkerson, Rachel Cohrs Zhang, and Katie Palmer